IMMUNI-D Trademark

Trademark Overview


On Thursday, November 7, 2024, a trademark application was filed for IMMUNI-D with the United States Patent and Trademark Office. The USPTO has given the IMMUNI-D trademark a serial number of 98842170. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, April 3, 2025. This trademark is owned by Translational and Fundamental Technologies Institute LLC. The IMMUNI-D trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely nutritional supplements and dietary supplements
immuni-d

General Information


Serial Number98842170
Word MarkIMMUNI-D
Filing DateThursday, November 7, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, April 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals, namely nutritional supplements and dietary supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTranslational and Fundamental Technologies Institute LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEncino, CA 91436

Trademark Events


Event DateEvent Description
Thursday, November 7, 2024NEW APPLICATION ENTERED
Thursday, November 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 2, 2025ASSIGNED TO EXAMINER
Thursday, April 3, 2025NON-FINAL ACTION E-MAILED
Thursday, April 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 3, 2025NON-FINAL ACTION WRITTEN